ProteinQure
Toronto, CA · Founded 2017 · 32 employees on LinkedIn · 3 known investors
ProteinQure is a clinical-stage biotech company that designs novel peptides for therapeutic delivery using its proprietary ProteinStudio computational platform powered by AI and molecular simulations. The company focuses on peptide-drug conjugates for tissue-specific and cell-specific delivery of therapeutics, with applications in oncology, renal disease, and blood-brain barrier transport.
Founders & leadership
ProteinQure was founded in 2017 by Tomas Babej.
TB
Tomas BabejFounder
Investors · 3
Frequently asked questions
- What does ProteinQure do?
- ProteinQure is a clinical-stage biotech company that designs novel peptides for therapeutic delivery using its proprietary ProteinStudio computational platform powered by AI and molecular simulations. The company focuses on peptide-drug conjugates for tissue-specific and cell-specific delivery of therapeutics, with applications in oncology, renal disease, and blood-brain barrier transport.
- Who founded ProteinQure?
- ProteinQure was founded by Tomas Babej in 2017.
- Who are ProteinQure's investors?
- ProteinQure's investors include Golden Ventures, Intrepid Growth Partners, Kensington Capital Partners Limited.
- Where is ProteinQure headquartered?
- ProteinQure is headquartered in Toronto, CA.